Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukiko Noguchi

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Reproductive Medicine and Biology|April 11, 2020
Equivalent clinical outcome after vitrified-thawed blastocyst transfer using semi-automated embryo vitrification system compared with manual vitrification methodAtsuko Miwa, Yukiko Noguchi, Kayo Hosoya, et al.
Vascular Pharmacology|June 25, 2005
A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in ratsHironori Yuyama, Akira Fujimori, Masanao Sanagi, et al.
European Journal of Pharmacology|February 9, 2012
Effects of α1-adrenoceptor antagonists on phenylephrine-induced salivary secretion and intraurethral pressure elevation in anesthetized ratsHiroko Yanai-Inamura, Akiyoshi Ohtake, Yukiko Noguchi, et al.
Biological & Pharmaceutical Bulletin|January 7, 2012
Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtypeShuichi Sato, Toshiki Hatanaka, Hironori Yuyama, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Pharmacological characterization of YM598, a selective endothelin-A receptor antagonistKatsumi Sudoh, Hironori Yuyama, Yukiko Noguchi, et al.
Molecular Carcinogenesis|April 10, 2015
Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovaryNozomu Yanaihara, Yukihiro Hirata, Noriko Yamaguchi, et al.
Anticancer Research|July 27, 2022
Cumulative Summation Analysis of Learning Curve for Robotic-assisted Hysterectomy in Patients With Gynecologic TumorsFusanori Yotsumoto, Ayako Sanui, Tomohiro Ito, et al.
Scientific Reports|November 23, 2017
Protocadherin-αC2 is required for diffuse projections of serotonergic axonsShota Katori, Yukiko Noguchi-Katori, Atsushi Okayama, et al.
European Journal of Pharmacology|September 15, 2004
Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonistHironori Yuyama, Yukiko Noguchi, Akira Fujimori, et al.
The Journal of Biological Chemistry|October 3, 2009
Total expression and dual gene-regulatory mechanisms maintained in deletions and duplications of the Pcdha clusterYukiko Noguchi, Takahiro Hirabayashi, Shota Katori, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Reproductive Medicine and Biology|April 11, 2020
Equivalent clinical outcome after vitrified-thawed blastocyst transfer using semi-automated embryo vitrification system compared with manual vitrification methodAtsuko Miwa, Yukiko Noguchi, Kayo Hosoya, et al.
Vascular Pharmacology|June 25, 2005
A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in ratsHironori Yuyama, Akira Fujimori, Masanao Sanagi, et al.
European Journal of Pharmacology|February 9, 2012
Effects of α1-adrenoceptor antagonists on phenylephrine-induced salivary secretion and intraurethral pressure elevation in anesthetized ratsHiroko Yanai-Inamura, Akiyoshi Ohtake, Yukiko Noguchi, et al.
Biological & Pharmaceutical Bulletin|January 7, 2012
Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtypeShuichi Sato, Toshiki Hatanaka, Hironori Yuyama, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Pharmacological characterization of YM598, a selective endothelin-A receptor antagonistKatsumi Sudoh, Hironori Yuyama, Yukiko Noguchi, et al.
Molecular Carcinogenesis|April 10, 2015
Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovaryNozomu Yanaihara, Yukihiro Hirata, Noriko Yamaguchi, et al.
Anticancer Research|July 27, 2022
Cumulative Summation Analysis of Learning Curve for Robotic-assisted Hysterectomy in Patients With Gynecologic TumorsFusanori Yotsumoto, Ayako Sanui, Tomohiro Ito, et al.
Scientific Reports|November 23, 2017
Protocadherin-αC2 is required for diffuse projections of serotonergic axonsShota Katori, Yukiko Noguchi-Katori, Atsushi Okayama, et al.
European Journal of Pharmacology|September 15, 2004
Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonistHironori Yuyama, Yukiko Noguchi, Akira Fujimori, et al.
The Journal of Biological Chemistry|October 3, 2009
Total expression and dual gene-regulatory mechanisms maintained in deletions and duplications of the Pcdha clusterYukiko Noguchi, Takahiro Hirabayashi, Shota Katori, et al.
Pageof 4